O.C.G.A.
O.C.G.A.

O.C.G.A. § 31-51-10 (2019)

Sunset

✓ O.C.G.A. — 2019 edition (Public.Resource.Org Release 73)
Code text and O.C.G.A. statutory annotations on this page reflect the 2019 Official Code of Georgia Annotated (Public.Resource.Org Release 73, 2019-08-21; public domain per Georgia v. Public.Resource.Org, 2020). The Syfert case-law annotations in Notes of Decisions, below, are current.
Find cases: SyfertCases citing this section GA-LEGlegis.ga.gov (official) JustiaJustia CornellLII Search CasesGoogle Scholar

This chapter shall stand repealed on July 1, 2020.

History

Code 1981, § 31-51-10, enacted by Ga. L. 2015, p. 49, § 4-1/HB 1.

CHAPTER 52 TERMINALLY ILL PATIENT’S RIGHT TO TRY INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES Sec.

Sec. Short title. Legislative findings. Definitions. Eligibility criteria. Written informed consent. Manufacturers permitted to make investigational drugs, biological products, or devices available. Coverage under health benefit

plan permitted but not required.